CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the recipient of a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 1 shares, a decrease of 100.0% from the September 30th total of 69,971 shares. Based on an average daily volume of 14,103,269 shares, the short-interest ratio is presently 0.0 days.
CNBX Pharmaceuticals Stock Up 100.0%
CNBX stock opened at $0.00 on Tuesday. CNBX Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.00.
About CNBX Pharmaceuticals
CNBX Pharmaceuticals Corp. is a biotechnology company focused on the research and development of cannabinoid-based medical treatments. The company has investigated the potential use of cannabis-derived compounds in oncology and other therapeutic applications.
Its activities have included laboratory research, development of cannabinoid formulations, and evaluation of cannabis compounds for potential effects on cancer cells. CNBX has also pursued technologies intended to support the screening and analysis of medical cannabis and cannabinoid products.
The company has been associated with research and development operations in Israel.
Featured Articles
- Five stocks we like better than CNBX Pharmaceuticals
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for CNBX Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
